Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cell-free translation and purification of Arabidopsis thaliana regulator of G signaling 1 protein.

Li B, Makino SI, Beebe ET, Urano D, Aceti DJ, Misenheimer TM, Peters J, Fox BG, Jones AM.

Protein Expr Purif. 2016 Oct;126:33-41. doi: 10.1016/j.pep.2016.04.016. Epub 2016 May 6.

2.

Low-molecular-weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a reply to rebuttal.

Buyue Y, Misenheimer TM, Sheehan JP.

J Thromb Haemost. 2013 Mar;11(3):565-6. doi: 10.1111/jth.12136. No abstract available.

3.

Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.

Buyue Y, Misenheimer TM, Sheehan JP.

J Thromb Haemost. 2012 Oct;10(10):2086-98. doi: 10.1111/j.1538-7836.2012.04892.x.

4.

The regulation of factor IXa by supersulfated low molecular weight heparin.

Misenheimer TM, Sheehan JP.

Biochemistry. 2010 Nov 23;49(46):9997-10005. doi: 10.1021/bi100906q. Epub 2010 Oct 27.

5.
6.

Biophysical characterization of the signature domains of thrombospondin-4 and thrombospondin-2.

Misenheimer TM, Mosher DF.

J Biol Chem. 2005 Dec 16;280(50):41229-35. Epub 2005 Oct 24.

7.

Structure of the calcium-rich signature domain of human thrombospondin-2.

Carlson CB, Bernstein DA, Annis DS, Misenheimer TM, Hannah BL, Mosher DF, Keck JL.

Nat Struct Mol Biol. 2005 Oct;12(10):910-4. Epub 2005 Sep 25.

8.

A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2+ binding.

Hannah BL, Misenheimer TM, Pranghofer MM, Mosher DF.

J Biol Chem. 2004 Dec 10;279(50):51915-22. Epub 2004 Sep 28.

9.

Interactions among the three structural motifs of the C-terminal region of human thrombospondin-2.

Misenheimer TM, Hannah BL, Annis DS, Mosher DF.

Biochemistry. 2003 May 6;42(17):5125-32.

PMID:
12718556
10.
11.

Expression of recombinant matrix components using baculoviruses.

Mosher DF, Huwiler KG, Misenheimer TM, Annis DS.

Methods Cell Biol. 2002;69:69-81. No abstract available.

PMID:
12071009
12.

Disulfide connectivity of recombinant C-terminal region of human thrombospondin 2.

Misenheimer TM, Hahr AJ, Harms AC, Annis DS, Mosher DF.

J Biol Chem. 2001 Dec 7;276(49):45882-7. Epub 2001 Oct 4.

13.

Physical characterization of the procollagen module of human thrombospondin 1 expressed in insect cells.

Misenheimer TM, Huwiler KG, Annis DS, Mosher DF.

J Biol Chem. 2000 Dec 29;275(52):40938-45.

14.

Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2.

Panetti TS, Chen H, Misenheimer TM, Getzler SB, Mosher DF.

J Lab Clin Med. 1997 Feb;129(2):208-16.

PMID:
9016857
15.

Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.

Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy-Ullrich JE.

J Biol Chem. 1995 Mar 31;270(13):7304-10.

16.

Calcium ion binding to thrombospondin 1.

Misenheimer TM, Mosher DF.

J Biol Chem. 1995 Jan 27;270(4):1729-33.

17.

Biochemical basis of warfarin and bromadiolone resistance in the house mouse, Mus musculus domesticus.

Misenheimer TM, Lund M, Baker EM, Suttie JW.

Biochem Pharmacol. 1994 Feb 11;47(4):673-8.

PMID:
8129744
18.

Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase.

Hogg PJ, Owensby DA, Mosher DF, Misenheimer TM, Chesterman CN.

J Biol Chem. 1993 Apr 5;268(10):7139-46.

19.

Modulation of fibrinolysis by thrombospondin.

Mosher DF, Misenheimer TM, Stenflo J, Hogg PJ.

Ann N Y Acad Sci. 1992 Dec 4;667:64-9. Review.

PMID:
1309073
20.

Warfarin resistance in a Chicago strain of rats.

Misenheimer TM, Suttie JW.

Biochem Pharmacol. 1990 Nov 1;40(9):2079-84.

PMID:
2242035

Supplemental Content

Loading ...
Support Center